BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 19797447)

  • 1. Combination treatment with quetiapine in bipolar disorder patients.
    Basu D; Chakraborty K
    Am J Psychiatry; 2009 Oct; 166(10):1185; author reply 1186-7. PubMed ID: 19797447
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence.
    Stedman M; Pettinati HM; Brown ES; Kotz M; Calabrese JR; Raines S
    Alcohol Clin Exp Res; 2010 Oct; 34(10):1822-31. PubMed ID: 20626727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divalproex sodium and quetiapine treatment of a pedophile with bipolar spectrum disorder.
    Wang SC; Kao YC; Liu YP
    J Neuropsychiatry Clin Neurosci; 2014; 26(3):E47-8. PubMed ID: 25093789
    [No Abstract]   [Full Text] [Related]  

  • 4. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS; Konarski JZ; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA; Brecher M; Paulsson B
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N; Mullen J; Paulsson B; Vågerö M
    J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
    Buckley PF; Paulsson B; Brecher M
    J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
    Yatham LN; Vieta E; Young AH; Möller HJ; Paulsson B; Vågerö M
    Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and tolerability of quetiapine in the treatment of acute mania in bipolar disorder.
    Adler CM; Fleck DE; Brecher M; Strakowski SM
    J Affect Disord; 2007; 100 Suppl 1():S15-22. PubMed ID: 17383737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quetiapine for acute mania in bipolar disorder.
    Brahm NC; Gutierres SL; Carnahan RM
    Am J Health Syst Pharm; 2007 May; 64(10):1045-53. PubMed ID: 17494904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.
    Woodward TC; Tafesse E; Quon P; Lazarus A
    Pharmacoeconomics; 2010; 28(9):751-64. PubMed ID: 20623994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monotherapy with lithium or valproate or respectively combination therapy with quetiapine have similar effect on cognitive functions in Chinese euthymic patients with bipolar disorder: a cross-sectional survey.
    Lin Y; Lin Y; Li X; Lao G; Jiang Z; Ye B; Lin W; Liu Y; Cao L
    J Clin Psychopharmacol; 2013 Dec; 33(6):817-9. PubMed ID: 23963059
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of bipolar depression: making sensible decisions.
    Citrome L
    CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new BALANCE in bipolar I disorder.
    Licht RW
    Lancet; 2010 Jan; 375(9712):350-2. PubMed ID: 20092883
    [No Abstract]   [Full Text] [Related]  

  • 15. The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s).
    Barzman DH; DelBello MP; Adler CM; Stanford KE; Strakowski SM
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):665-70. PubMed ID: 17201610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bipolar drug development: are we getting closer to the real world?
    Calabrese JR; Kemp DE
    Am J Psychiatry; 2008 Oct; 165(10):1234-6. PubMed ID: 18829876
    [No Abstract]   [Full Text] [Related]  

  • 17. Neutropenia associated with the comedication of quetiapine and valproate in 2 elderly patients.
    Hung WC; Hsieh MH
    J Clin Psychopharmacol; 2012 Jun; 32(3):416-7. PubMed ID: 22561472
    [No Abstract]   [Full Text] [Related]  

  • 18. Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study.
    Altamura AC; Mundo E; Dell'Osso B; Tacchini G; Buoli M; Calabrese JR
    J Affect Disord; 2008 Sep; 110(1-2):135-41. PubMed ID: 18329720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of quetiapine with lithium or divalproex for maintenance treatment of bipolar I disorder.
    Woodward TC; Tafesse E; Quon P; Kim J; Lazarus A
    J Med Econ; 2009; 12(4):259-68. PubMed ID: 19769548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of conclusions about quetiapine.
    McIntyre RS
    Am J Health Syst Pharm; 2008 Jan; 65(2):114-5; author reply 115-6. PubMed ID: 18192252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.